Talis Biomedical Corporation (TLIS)

Market Cap	5.18M -65.7%
Revenue (ttm)	408.00K -85.7%
Net Income	-51.03M
EPS	-28.02
Shares Out	1.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,306
Open	2.800
Previous Close	1.600
Day's Range	2.800 - 2.840
52-Week Range	1.040 - 2.840
Beta	1.32
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2025

About Talis Biomedical

Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 99
• Stock Exchange: OTCMKTS
• Ticker Symbol: TLIS

Financial Performance

In 2023, Talis Biomedical's revenue was $2.13 million, a decrease of -55.65% compared to the previous year's $4.81 million. Losses were -$62.01 million, -45.13% less than in 2022.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Dec 19, 2025

Data Sources Report a data error